Showing 1 to 1 of 1 results
cnn.com
🌐 85% Global Worthiness


CVS Faces Class-Action Lawsuit Over Obesity Drug Coverage
A class-action lawsuit targets CVS Caremark for removing coverage of Eli Lilly's Zepbound, replacing it with Novo Nordisk's Wegovy, despite medical professionals arguing the drugs aren't interchangeable, impacting an estimated 25-30 million people.
CVS Faces Class-Action Lawsuit Over Obesity Drug Coverage
A class-action lawsuit targets CVS Caremark for removing coverage of Eli Lilly's Zepbound, replacing it with Novo Nordisk's Wegovy, despite medical professionals arguing the drugs aren't interchangeable, impacting an estimated 25-30 million people.
Progress
24% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results